Coverage Restrictions for Hepatitis C Drugs
How insurance providers deny hepatitis C patients lifesaving drugs
October 16, 2015
by Sony Salzman
Doctors say up to 80 percent of patients are denied expensive but effective drugs like Harvoni.
Amber Rojas was almost eight months pregnant when she learned she had hepatitis C. After her daughter was born on Dec. 23, 2014, Rojas had hoped to start treatment with a newly approved, highly effective drug called Harvoni.
Continue reading this entire article:
Case Study Suggests Milk Thistle Is Potent Against Hep C
AbbVie to Add Liver Warning on Hep C Drugs